Search research articles
Contact Us
Filters
Showing results (91-100 of 132) with videos related to
Page
of 14
Sort By:
Current Oncology Reports
|
February 19, 2005
Intensity-modulated radiotherapy: is xerostomia still prevalent?
Mark S Chambers, Adam S Garden, David Rosenthal, et al.
Oral Oncology
|
June 24, 2014
Phase II multicenter trial of Caphosol for the reduction of mucositis in patients receiving radiation therapy for head and neck cancer
Nikhil G Rao, Andy Trotti, Jongphil Kim, et al.
Head & Neck
|
March 13, 2019
Tumor-induced hypophosphatemic osteomalacia caused by a mesenchymal tumor of the mandible managed by a segmental mandibulectomy and microvascular reconstruction with a free fibula flap
Rishabh P Acharya, Alexander M Won, Bryan S Moon, et al.
Journal of Medicinal Chemistry
|
November 13, 2004
An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA alpha5 receptors with cognition enhancing properties
Mark S Chambers, John R Atack, Robert W Carling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2012
A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck
Carol M Lewis, Bonnie S Glisson, Lei Feng, et al.
Plos One
|
July 6, 2017
Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis
Cielito C Reyes-Gibby, Stephanie C Melkonian, Jian Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 15, 2007
Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia
Mark S Chambers, Christopher Uwe Jones, Merrill A Biel, et al.
Oral Oncology
|
November 21, 2007
Erratum to "Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 2: Phase I study"
Mark S Chambers, Terence J Fleming, Béla B Toth, et al.
Oral Oncology
|
May 22, 2016
Osteoradionecrosis in patients with salivary gland malignancies
J Rhet Tucker, Li Xu, Erich M Sturgis, et al.
Journal of Medicinal Chemistry
|
May 16, 2003
Identification of a novel, selective GABA(A) alpha5 receptor inverse agonist which enhances cognition
Mark S Chambers, John R Atack, Howard B Broughton, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 132) with videos related to
Sort By:
Page
of 14
Current Oncology Reports
|
February 19, 2005
Intensity-modulated radiotherapy: is xerostomia still prevalent?
Mark S Chambers, Adam S Garden, David Rosenthal, et al.
Oral Oncology
|
June 24, 2014
Phase II multicenter trial of Caphosol for the reduction of mucositis in patients receiving radiation therapy for head and neck cancer
Nikhil G Rao, Andy Trotti, Jongphil Kim, et al.
Head & Neck
|
March 13, 2019
Tumor-induced hypophosphatemic osteomalacia caused by a mesenchymal tumor of the mandible managed by a segmental mandibulectomy and microvascular reconstruction with a free fibula flap
Rishabh P Acharya, Alexander M Won, Bryan S Moon, et al.
Journal of Medicinal Chemistry
|
November 13, 2004
An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA alpha5 receptors with cognition enhancing properties
Mark S Chambers, John R Atack, Robert W Carling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2012
A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck
Carol M Lewis, Bonnie S Glisson, Lei Feng, et al.
Plos One
|
July 6, 2017
Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis
Cielito C Reyes-Gibby, Stephanie C Melkonian, Jian Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 15, 2007
Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia
Mark S Chambers, Christopher Uwe Jones, Merrill A Biel, et al.
Oral Oncology
|
November 21, 2007
Erratum to "Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 2: Phase I study"
Mark S Chambers, Terence J Fleming, Béla B Toth, et al.
Oral Oncology
|
May 22, 2016
Osteoradionecrosis in patients with salivary gland malignancies
J Rhet Tucker, Li Xu, Erich M Sturgis, et al.
Journal of Medicinal Chemistry
|
May 16, 2003
Identification of a novel, selective GABA(A) alpha5 receptor inverse agonist which enhances cognition
Mark S Chambers, John R Atack, Howard B Broughton, et al.
Page
of 14